ArticleCancers2026

Evaluating Adjuvant Radiation Therapy Survival Benefit in Early-Stage HER2-Positive Invasive Breast Cancer Following Breast-Conserving Surgery: A National Cohort Aligned with NRG-BR008 HERO Trial.

Jonathon S Cummock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.